The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Prostate cancer (PCa) induced death is the predominant cause of cancer-related death among men in 48 countries. After radical treatment, biochemical recurrence has become an important factor for prognosis. The early detection and diagnosis of recurrent lesions are very helpful in guiding treatment and improving the prognosis. PET/CT is a promising method for early detection of lesions in patients with biochemical recurrence of prostate cancer. This article reviews the progress of the research on PET/CT in the PCa biochemical recurrence and aims to introduce new technologies and provide more direction for future research.

Cite

CITATION STYLE

APA

Jiang, J., Tang, X., Pu, Y., Yang, Y., Yang, C., Yang, F., … Chen, L. (2022, May 27). The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence. Frontiers in Endocrinology. Frontiers Media S.A. https://doi.org/10.3389/fendo.2022.897513

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free